93.47
전일 마감가:
$93.89
열려 있는:
$94.05
하루 거래량:
1.48M
Relative Volume:
0.85
시가총액:
$12.51B
수익:
$2.51B
순이익/손실:
$185.56M
주가수익비율:
69.75
EPS:
1.34
순현금흐름:
$517.59M
1주 성능:
-1.06%
1개월 성능:
+8.95%
6개월 성능:
+65.11%
1년 성능:
+3.32%
Globus Medical Inc Stock (GMED) Company Profile
명칭
Globus Medical Inc
전화
610-930-1800
주소
2560 GENERAL ARMISTEAD AVENUE, AUDUBON, PA
GMED을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
GMED
Globus Medical Inc
|
93.47 | 12.57B | 2.51B | 185.56M | 517.59M | 1.34 |
|
ABT
Abbott Laboratories
|
121.76 | 214.80B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
SYK
Stryker Corp
|
363.78 | 138.62B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
BSX
Boston Scientific Corp
|
88.07 | 133.46B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
MDT
Medtronic Plc
|
96.76 | 126.92B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
84.35 | 49.03B | 5.88B | 1.34B | 799.60M | 2.3489 |
Globus Medical Inc Stock (GMED) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-11-07 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2025-11-07 | 업그레이드 | Truist | Hold → Buy |
| 2025-10-28 | 재개 | Stifel | Hold |
| 2025-05-27 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2025-01-10 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2024-12-02 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2024-08-07 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2024-05-20 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2024-03-18 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2023-10-20 | 개시 | ROTH MKM | Buy |
| 2023-09-19 | 업그레이드 | Stifel | Hold → Buy |
| 2023-03-30 | 업그레이드 | Canaccord Genuity | Hold → Buy |
| 2023-02-13 | 다운그레이드 | BofA Securities | Buy → Underperform |
| 2023-02-10 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2023-02-10 | 다운그레이드 | Loop Capital | Buy → Hold |
| 2023-02-10 | 다운그레이드 | Needham | Buy → Hold |
| 2023-02-10 | 다운그레이드 | Truist | Buy → Hold |
| 2023-02-10 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2022-10-18 | 개시 | Barclays | Overweight |
| 2022-10-12 | 개시 | Jefferies | Buy |
| 2022-04-13 | 재개 | Truist | Buy |
| 2022-03-28 | 개시 | Wells Fargo | Overweight |
| 2022-01-04 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2021-12-13 | 업그레이드 | BofA Securities | Underperform → Buy |
| 2021-12-10 | 개시 | RBC Capital Mkts | Outperform |
| 2021-10-29 | 개시 | Loop Capital | Buy |
| 2021-02-18 | 재개 | Needham | Buy |
| 2020-12-08 | 개시 | Citigroup | Buy |
| 2020-10-20 | 개시 | Stifel | Hold |
| 2020-08-06 | 재확인 | Needham | Buy |
| 2020-08-06 | 업그레이드 | Northland Capital | Market Perform → Outperform |
| 2020-07-21 | 개시 | Northland Capital | Market Perform |
| 2020-07-06 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2020-05-08 | 재확인 | Needham | Buy |
| 2020-03-18 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2020-01-08 | 개시 | SunTrust | Buy |
| 2019-12-12 | 업그레이드 | Wells Fargo | Market Perform → Outperform |
| 2019-08-02 | 재확인 | Needham | Buy |
| 2019-05-24 | 다운그레이드 | Wells Fargo | Outperform → Market Perform |
| 2019-05-03 | 재확인 | Needham | Buy |
| 2019-02-28 | 업그레이드 | UBS | Neutral → Buy |
| 2019-01-02 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2018-08-02 | 재확인 | Needham | Buy |
| 2018-06-27 | 다운그레이드 | BofA/Merrill | Neutral → Underperform |
| 2018-06-01 | 개시 | Cantor Fitzgerald | Overweight |
| 2018-05-03 | 재확인 | Needham | Buy |
| 2018-04-04 | 업그레이드 | Needham | Hold → Buy |
모두보기
Globus Medical Inc 주식(GMED)의 최신 뉴스
The Truth About Globus Medical Inc (GMED): Is This ‘Boring’ Stock Actually a Secret Game-Changer - AD HOC NEWS
Risk On: Will Globus Medical Inc announce a stock splitJuly 2025 Final Week & Weekly High Potential Alerts - baoquankhu1.vn
Globus Medical Inc (NYSE:GMED) Emerges as a Minervini-Style Growth Momentum Candidate - Chartmill
Pullback Watch: Can Globus Medical Inc reach all time highs this yearMarket Performance Report & Precise Buy Zone Identification - baoquankhu1.vn
A Look At Globus Medical (GMED) Valuation As Strong 2025 And 2026 Guidance Lifts Investor Confidence - Sahm
Is Globus Medical Inc.’s growth already priced inQuarterly Trade Report & Technical Entry and Exit Alerts - baoquankhu1.vn
Insider Move: Kyle Kline Exercises Options, Realizing $125K At Globus Medical - Benzinga
Fed Meeting: How resilient is Globus Medical Inc stock in market downturns2025 Earnings Surprises & High Return Trade Guides - moha.gov.vn
Globus Medical (GMED) Valuation Check After Strong Q4 2025 Beat And Upgraded Sales Outlook - Yahoo Finance
Market Outlook: Can Globus Medical Inc stock hit record highs againQuarterly Portfolio Review & AI Powered Buy/Sell Recommendations - moha.gov.vn
IPO Launch: How Globus Medical Inc stock reacts to Fed rate cutsQuarterly Risk Review & Accurate Intraday Trading Signals - moha.gov.vn
Sectors Review: Will Globus Medical Inc. Class stock outperform energy sector in 2025Portfolio Return Summary & High Conviction Buy Zone Picks - Bộ Nội Vụ
Did Strong Q4 2025 Beat and Higher 2026 Sales Outlook Just Shift Globus Medical's (GMED) Investment Narrative? - Yahoo Finance
2 Healthcare Stocks to Keep an Eye On and 1 We Ignore - Barchart.com
Is Globus Medical (GMED) Priced Attractively After Recent Share Price Steadiness? - Yahoo Finance
Globus Medical (NYSE:GMED) CFO Kyle Kline Sells 3,594 Shares - MarketBeat
Kline Kyle, Globus Medical CFO, sells $363k in Gmed stock - Investing.com Canada
Globus Medical (GMED) director Norwalk sells $202k in shares By Investing.com - Investing.com India
Globus Medical (GMED) director Norwalk sells $202k in shares - Investing.com
Globus Medical (NYSE:GMED) Director Sells $202,200.00 in Stock - MarketBeat
Globus Medical Insider Sold Shares Worth $363,353, According to a Recent SEC Filing - marketscreener.com
Why Globus Medical (GMED) Is Up 8.2% After Raising 2026 Revenue Guidance And Integration Outlook - simplywall.st
Stifel maintains GMED buy rating, $92 target amid NVRO buyout - MSN
Audubon’s Globus Medical Wins $9.5 Million Settlement - MSN
Should You Buy Globus Medical (GMED) After Golden Cross? - MSN
Globus Medical’s blockbuster finish sets a high-stakes 2026 showdown - MSN
Globus Medical’s Blockbuster Finish Sets a High-Stakes 2026 Showdown - MyChesCo
Retail Trends: Can Globus Medical Inc stock maintain growth trajectoryTrade Exit Report & Verified Chart Pattern Trade Signals - moha.gov.vn
Why Globus Medical (GMED) is a top growth stock for the long term - MSN
Globus Medical 2026 Outlook: Why M&A Math Mires The Valuation (NYSE:GMED) - Seeking Alpha
GMED: Canaccord Genuity Raises Price Target to $112 | GMED Stock News - GuruFocus
Why Globus Medical (GMED) is a Top Growth Stock for the Long-Term - Yahoo Finance
Globus Medical stock price target raised to $112 by Canaccord on strong results - Investing.com Canada
SG Americas Securities LLC Acquires 275,150 Shares of Globus Medical, Inc. $GMED - MarketBeat
Globus Medical Inc (NYSE:GMED): A GARP Stock with Strong Growth and a Reasonable Price - Chartmill
Barclays Keeps Their Buy Rating on Globus Medical (GMED) - The Globe and Mail
Is Globus Medical Inc. stock dividend yield sustainable2025 Trade Ideas & Long-Term Growth Stock Strategies - ulpravda.ru
Can Globus Medical Inc. stock maintain growth trajectoryTrade Exit Summary & Entry Point Confirmation Signals - ulpravda.ru
Why Globus Medical Inc. stock could benefit from AI revolution2025 Top Gainers & Community Shared Stock Ideas - ulpravda.ru
Will Globus Medical Inc. stock benefit from automationNew Guidance & Stock Portfolio Risk Control - ulpravda.ru
GMED insider (Form 144) plans sale of 3,594 common shares - Stock Titan
Globus Medical jumps 9% after upbeat revenue and earnings outloo - GuruFocus
GMED (GMED) holder files to sell 2,000 shares after RSU vesting - Stock Titan
Globus Medical jumps 9% after upbeat revenue and earnings outlook - Yahoo Finance
Globus Medical (NYSE:GMED) Sets New 12-Month HighWhat's Next? - MarketBeat
Globus Medical (GMED) Price Target Raised to $115.00 by Piper Sa - GuruFocus
Globus Medical stock hits all-time high at 99.5 USD By Investing.com - Investing.com Canada
Globus Medical climbs on better-than-expected Q4, FY outlook - TradingView — Track All Markets
Globus Medical Projects $3.22B Revenue for Fiscal 2026 Amid Strong Q4 Guidance - Intellectia AI
Globus Medical (NYSE:GMED) Updates FY 2026 Earnings Guidance - MarketBeat
US-based Globus Medical anticipates 25.2% sales increase in Q4 2025 - Medical Buyer
Globus Medical Inc (GMED) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):